1. Fan, Yizeng, Hou, Tao, Gao, Yang, Zeng, Jin, Li, Lei. 2021. Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer. In Autophagy, 17, 4386-4400. doi:10.1080/15548627.2021.1917130. https://pubmed.ncbi.nlm.nih.gov/34034634/
2. Dan, Weichao, Fan, Yizeng, Wang, Yuzhao, Zeng, Jin, Li, Lei. 2024. The Tumor Suppressor TPD52-Governed Endoplasmic Reticulum Stress is Modulated by APCCdc20. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2405441. doi:10.1002/advs.202405441. https://pubmed.ncbi.nlm.nih.gov/39401430/
3. Wang, Yuezhen, Fang, Jun, Gu, Feiying. 2022. MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells. In Molecular biotechnology, 64, 1003-1012. doi:10.1007/s12033-022-00475-3. https://pubmed.ncbi.nlm.nih.gov/35320453/
4. Miao, Lu, Jing, Li, Chen, Buze, Zeng, Tian, Chen, Youguo. . TPD52 is a Potential Prognostic Biomarker and Correlated with Immune Infiltration: A Pan-cancer Analysis. In Current molecular medicine, 24, 1413-1425. doi:10.2174/0115665240260252230919054858. https://pubmed.ncbi.nlm.nih.gov/38178662/
5. Cheng, Xiaolin, Li, Zhengdong, Jia, Xiaoqing, He, Qizhi, Zhuang, Zhigang. 2024. TPD52 is a prognostic biomarker and potential therapeutic target for ER+/PR+/HER2+ breast cancer. In Chinese clinical oncology, 13, 33. doi:10.21037/cco-23-156. https://pubmed.ncbi.nlm.nih.gov/38859601/
智鼠故事 
